Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
10.1053/j.gastro.2006.09.020
Saved in:
Main Authors: | Hadziyannis, S.J., Tassopoulos, N.C., Heathcote, E.J., Chang, T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S.G., Goodman, Z., Ma, J., Brosgart, C.L., Borroto-Esoda, K., Arterburn, S., Chuck, S.L. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/26684 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
by: Hadziyannis, S.J., et al.
Published: (2014) -
Clinical trial: Effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011) -
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
by: Marcellin, P., et al.
Published: (2016) -
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
by: Marcellin, P., et al.
Published: (2014) -
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant
by: Wai, C.-T., et al.
Published: (2012)